An Escalating Dose Study to Assess the Safety, Tolerability and Immunogenicity of a Herpes Simplex Virus DNA Vaccine, COR-1
Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2016.1221872
Full Text
Open PDFAbstract
Available in full text
Date
August 31, 2016
Authors
Publisher
Informa UK Limited